Home Isomorphic Labs partners with pharmaceutical firms for AI-driven drug discovery

Isomorphic Labs partners with pharmaceutical firms for AI-driven drug discovery

London-based AI startup Isomorphic Labs, which concentrates on drug discovery and emerged from Google’s DeepMind division in 2021, has revealed partnerships with two prominent pharmaceutical firms. These collaborations, worth approximately $3 billion, include initiatives to address various illnesses potentially. By joining forces with these industry-leading pharmaceutical companies, Isomorphic Labs aims to leverage its groundbreaking AI technology to revolutionize the process of drug development and enhance the overall effectiveness of treatments. Through these partnerships, the firm seeks to accelerate the discovery of novel therapeutics, ultimately improving patient outcomes and contributing to advancements in global healthcare. Isomorphic Labs has obtained initial payments of $45 million and $37.5 million from these partners and may receive up to $1.7 billion and $1.2 billion more based on performance-related milestones.

Isomorphic Labs and AlphaFold

Established by CEO Demis Hassabis, Isomorphic Labs is behind AlphaFold, an AI system that predicts human protein structures and allows researchers to find potential new drug target pathways. This groundbreaking technology has garnered significant attention in the scientific and medical communities for its potential impact on drug discovery and development. With the additional funding from its partners, Isomorphic Labs aims to accelerate advancements in this AI-driven research, ultimately contributing to breakthroughs in understanding and treating a wide range of diseases.

These diseases include revolutionizing protein research. Conventional protein structure analysis can take years of hands-on work, whereas AlphaFold can produce predictions in just days. Using the AlphaFold 2 model, Isomorphic and DeepMind recently created and synthesized a novel drug to treat hepatocellular carcinoma, the most common type of liver cancer.

Financial impact and faster drug development

According to Hassabis, these partnerships provide a “compelling” mix of innovative drug design techniques and cutting-edge science, potentially alleviating financial stress on Isomorphic Labs, which experienced a $2.4 million loss in 2021. This collaboration aims to accelerate the drug development process, making it more cost-effective and yield faster results for patients suffering from these neglected diseases.

Fiona Marshall, president of biomedical research at one of the partnering firms, believes AlphaFold has the potential to transform drug discovery and expedite the creation of new, life-saving treatments by combining AI, data science, medicinal chemistry, and disease research expertise.

Featured Image Credit: Photo by Sofia Marquet; Pexels

About ReadWrite’s Editorial Process

The ReadWrite Editorial policy involves closely monitoring the tech industry for major developments, new product launches, AI breakthroughs, video game releases and other newsworthy events. Editors assign relevant stories to staff writers or freelance contributors with expertise in each particular topic area. Before publication, articles go through a rigorous round of editing for accuracy, clarity, and to ensure adherence to ReadWrite's style guidelines.

Deanna Ritchie
Former Editor

Deanna was an editor at ReadWrite until early 2024. Previously she worked as the Editor in Chief for Startup Grind, Editor in Chief for Calendar, editor at Entrepreneur media, and has over 20+ years of experience in content management and content development.

Get the biggest tech headlines of the day delivered to your inbox

    By signing up, you agree to our Terms and Privacy Policy. Unsubscribe anytime.

    Tech News

    Explore the latest in tech with our Tech News. We cut through the noise for concise, relevant updates, keeping you informed about the rapidly evolving tech landscape with curated content that separates signal from noise.

    In-Depth Tech Stories

    Explore tech impact in In-Depth Stories. Narrative data journalism offers comprehensive analyses, revealing stories behind data. Understand industry trends for a deeper perspective on tech's intricate relationships with society.

    Expert Reviews

    Empower decisions with Expert Reviews, merging industry expertise and insightful analysis. Delve into tech intricacies, get the best deals, and stay ahead with our trustworthy guide to navigating the ever-changing tech market.